10x Genomics 

M$335.54
167
+M$0+0% Tuesday 13:34

Statistics

Day High
335.54
Day Low
335.54
52W High
363
52W Low
150
Volume
0
Avg. Volume
88
Mkt Cap
39.48B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.47
-0.22
0.03
0.28
Expected EPS
-0.269849
Actual EPS
N/A

Financials

-6.9%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
23.72BRevenue
-1.64BNet Income

Analyst Ratings

$277.44Average Price Target
The highest estimate is 340.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
36%
Hold
64%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TXG.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap19.48B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with technologies that overlap with 10x Genomics' offerings.
Pacific Biosciences of California
PACB
Mkt Cap404.68M
Pacific Biosciences offers long-read sequencing technologies that compete with 10x Genomics' products for genomic and transcriptomic analysis.
Bionano Genomics
BNGO
Mkt Cap13.31M
Bionano Genomics provides optical genome mapping solutions, which compete with 10x Genomics' chromosomal conformation capture technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.55B
Intellia Therapeutics is involved in CRISPR gene editing, a field that requires detailed genomic analysis, where 10x Genomics' products are used.
CRISPR Therapeutics
CRSP
Mkt Cap4.75B
CRISPR Therapeutics is another key player in the gene editing space, relying on genomic insights where 10x Genomics' technologies can be applied.
Editas Medicine
EDIT
Mkt Cap261.32M
Editas Medicine operates in the genome editing sector, competing for the same genomic analysis market as 10x Genomics.
Teladoc Health
TDOC
Mkt Cap940.15M
Teladoc Health, while primarily a telehealth company, is expanding into primary care and chronic condition monitoring, indirectly competing with 10x Genomics in the data analysis and personalized medicine space.
Guardant Health
GH
Mkt Cap12.31B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with 10x Genomics in the genomic analysis market for oncology.
Twist Bioscience
TWST
Mkt Cap3.08B
Twist Bioscience operates in the synthetic biology space, producing synthetic DNA that is used in many of the same applications as 10x Genomics' products.

About

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Show more...
CEO
Dr. Serge Saxonov Ph.D.
Employees
1239
Country
United States
ISIN
US88025U1097

Listings

0 Comments

Share your thoughts

FAQ

What is 10x Genomics stock price today?
The current price of TXG.MX is M$335.54 MXN — it has increased by +0% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange 10x Genomics stocks are traded under the ticker TXG.MX.
What is 10x Genomics market cap?
Today 10x Genomics has the market capitalization of 39.48B
When is the next 10x Genomics earnings date?
10x Genomics is going to release the next earnings report on May 06, 2026.
What were 10x Genomics earnings last quarter?
TXG.MX earnings for the last quarter are -2.24 MXN per share, whereas the estimation was -3.49 MXN resulting in a +35.89% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is 10x Genomics revenue for the last year?
10x Genomics revenue for the last year amounts to 23.72B MXN.
What is 10x Genomics net income for the last year?
TXG.MX net income for the last year is -1.64B MXN.
How many employees does 10x Genomics have?
As of April 11, 2026, the company has 1,239 employees.
In which sector is 10x Genomics located?
10x Genomics operates in the Healthcare sector.
When did 10x Genomics complete a stock split?
10x Genomics has not had any recent stock splits.
Where is 10x Genomics headquartered?
10x Genomics is headquartered in Pleasanton, United States.